Wang Song-tao, Chen Su, Guo Min, Liu Xiang-ming
Department of Biomedical Engineering, Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan 430074, China.
Brain Res. 2008 Mar 27;1201:34-40. doi: 10.1016/j.brainres.2007.12.068. Epub 2008 Jan 11.
Vanilloid receptor 1 (VR1) is a noxious receptor and a novel target for pain therapy. Cochinchinenin B (6-hydroxy-7-methoxy-3-(4'-hydroxybenzyl) chromone; CB) is one of the small-molecular components from the flavonoids of Dragon's Blood, a well-known herbal medicine to treat various types of pain. Using whole-cell patch clamp technique, we found that capsaicin (CAP)-activated currents (ICAP) was inhibited by CB with an IC50 of 0.92 mM in acutely isolated rat dorsal root ganglion (DRG) neurons. The inhibition was reversible and not competitive. We also found that the inhibition was neither voltage- nor agonist-dependent. The bind site was on the extracellular part of the channel since intracellular application of CB did not alter the inhibition effect on ICAP. In addition, CB inhibited CAP-evoked depolarization under current-clamp condition. Our findings indicate that CB may be a candidate in developing new analgesic drugs targeting the VR1 receptor.
香草酸受体1(VR1)是一种伤害性感受器,也是疼痛治疗的新靶点。柯西茄内酯B(6-羟基-7-甲氧基-3-(4'-羟基苄基)色酮;CB)是血竭类黄酮中的小分子成分之一,血竭是一种治疗各种疼痛的著名草药。采用全细胞膜片钳技术,我们发现辣椒素(CAP)激活电流(ICAP)在急性分离的大鼠背根神经节(DRG)神经元中被CB抑制,IC50为0.92 mM。这种抑制是可逆的,且非竞争性的。我们还发现这种抑制既不依赖电压也不依赖激动剂。结合位点在通道的细胞外部分,因为细胞内应用CB不会改变对ICAP的抑制作用。此外,在电流钳条件下,CB抑制了CAP诱发的去极化。我们的研究结果表明,CB可能是开发针对VR1受体的新型镇痛药的候选药物。